Literature DB >> 8720899

The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias.

M Demasi1, C A Penatti, R DeLucia, E J Bechara.   

Abstract

5-Aminolevulinic acid (ALA), a heme precursor accumulated during the clinical expression of acute intermittent porphyria, lead poisoning, and tyrosinosis, has been hypothesized to act as an endogenous source of oxyradicals. We now report oxidative effects on brain tissue of rats submitted to ALA treatment. Upon acute treatment (40 mg/kg body weight) increased total nonheme iron in the cortex (20%) was observed. After prolonged ALA administration (40 mg/kg body weight on alternate days during 2 weeks), the following indicators of oxidative stress were found to be significantly increased: CuZnSOD activity (67%) in total brain homogenate, total iron (68%) and ferritin (71%) in the cortex, ferritin in striatum (44%), protein carbonyls in homogenate of cerebral cortex (threefold) and 45Ca2+ uptake by cortical synaptosomes (45%). In addition, synaptic membranes prepared from whole brain assayed with the radioligand 3H-muscimol, revealed increased Kd values (twofold) of the high-affinity GABAergic receptor binding and formation of protein carbonyl groups, thiobarbituric acid reactive products, and conjugated dienes. In vitro, ALA produced similar effects upon the high affinity 3H-muscimol binding. No apparent alteration of either dopaminergic or serotonergic [3H]-ligand binding was observed. These results argue in favor of ALA-triggered oxidative stress in brain accompanied by iron metabolism alterations and GABAergic receptor damage, which may be implicated in the neuropsychiatric manifestations of the aforementioned porphyrias.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8720899     DOI: 10.1016/0891-5849(95)02035-7

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  23 in total

1.  Investigations into the mechanism of 2,3-dimercaptopropanol neurotoxicity.

Authors:  C W Nogueira; F A Soares; R C Bolzan; M C Jacques-Silva; D O Souza; J B Rocha
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

Review 2.  Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.

Authors:  Makiko Yasuda; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2019-01-18       Impact factor: 4.797

3.  5-Aminolevulinic acid inhibits [3H]muscimol binding to human and rat brain synaptic membranes.

Authors:  T Emanuelli; F W Pagel; L B Alves; A Regner; D O Souza
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

Review 4.  Psychiatric Aspects of Acute Porphyria: a Comprehensive Review.

Authors:  Laura Duque-Serrano; Liliana Patarroyo-Rodriguez; Dorothy Gotlib; Juan C Molano-Eslava
Journal:  Curr Psychiatry Rep       Date:  2018-02-02       Impact factor: 5.285

5.  Delta-aminolevulinic dehydratase is a proteasome interacting protein.

Authors:  Fawzia Bardag-Gorce; Samuel W French
Journal:  Exp Mol Pathol       Date:  2011-05-27       Impact factor: 3.362

Review 6.  Effects of ethanol on the proteasome interacting proteins.

Authors:  Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

7.  Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Chunli Yu; Jinglan Zhang; Miguel A Gama-Sosa; Daniela D Pollak; Stefanie Berger; John D Phillips; Winfried Edelmann; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2019-06-01       Impact factor: 6.150

Review 8.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

9.  The heme precursor delta-aminolevulinate blocks peripheral myelin formation.

Authors:  Natalia Felitsyn; Colin McLeod; Albert L Shroads; Peter W Stacpoole; Lucia Notterpek
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

10.  Urinary delta-ALA: a potential biomarker of exposure and neurotoxic effect in rats co-treated with a mixture of lead, arsenic and manganese.

Authors:  Vanda Andrade; M Luísa Mateus; M Camila Batoréu; Michael Aschner; A P Marreilha dos Santos
Journal:  Neurotoxicology       Date:  2013-06-11       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.